Post-traumatic osteomyelitis in Middle East war-wounded civilians: resistance to first-line antibiotics in selected bacteria over the decade 2006-2016.
Acinetobacter baumannii
/ isolation & purification
Adult
Anti-Bacterial Agents
/ pharmacology
Armed Conflicts
Databases, Factual
Drug Resistance, Multiple, Bacterial
Enterobacteriaceae
/ isolation & purification
Female
Humans
Male
Middle East
/ epidemiology
Osteomyelitis
/ drug therapy
Pseudomonas aeruginosa
/ isolation & purification
Retrospective Studies
Staphylococcus aureus
/ isolation & purification
Wounds and Injuries
/ complications
Young Adult
Bone biopsy
First-line antibiotics resistance
Middle East
Osteomyelitis
War-wounded
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
31 Jan 2019
31 Jan 2019
Historique:
received:
06
07
2018
accepted:
25
01
2019
entrez:
2
2
2019
pubmed:
2
2
2019
medline:
2
3
2019
Statut:
epublish
Résumé
War-wounded civilians in Middle East countries are at risk of post-traumatic osteomyelitis (PTO). We aimed to describe and compare the bacterial etiology and proportion of first-line antibiotics resistant bacteria (FLAR) among PTO cases in civilians from Syria, Iraq and Yemen admitted to the reconstructive surgical program of Médecins Sans Frontières (MSF) in Amman, Jordan, and to identify risk factors for developing PTO with FLAR bacteria. We retrospectively analyzed the laboratory database of the MSF program. Inclusion criteria were: patients from Iraq, Yemen or Syria, admitted to the Amman MSF program between October 2006 and December 2016, with at least one bone biopsy sample culture result. Only bone samples taken during first orthopedic surgery were included in the analysis. To assess factors associated with FLAR infection, logistic regression was used to estimate odds ratio (ORs) and 95% confidence intervals (CI). 558 (76.7%) among 727 patients included had ≥1 positive culture results. 318 were from Iraq, 140 from Syria and 100 from Yemen. Median time since injury was 19 months [IQR 8-40]. Among the 732 different bacterial isolates, we identified 228 Enterobacteriaceae (31.5%), 193 Staphylococcus aureus (26.3%), 99 Pseudomonas aeruginosa (13.5%), and 21 Acinetobacter baumanii (2.8%). Three hundred and sixty four isolates were FLAR: 86.2% of Enterobacteriaceae, 53.4% of Pseudomonas aeruginosa, 60.5% of S. aureus and 45% of Acinetobacter baumannii. There was no difference in bacterial etiology or proportion of FLAR according to the country of origin. In multivariate analysis, a FLAR infection was associated with an infection of the lower extremity, with a time since the injury ≤12 months compared with time > 30 months and with more than 3 previous surgeries. Enterobacteriaceae were frequently involved in PTO in war wounded civilians from Iraq, Yemen and Syria between 2006 and 2016. Proportion of FLAR was high, particularly among Enterobacteriaceae, regardless of country of origin.
Sections du résumé
BACKGROUND
BACKGROUND
War-wounded civilians in Middle East countries are at risk of post-traumatic osteomyelitis (PTO). We aimed to describe and compare the bacterial etiology and proportion of first-line antibiotics resistant bacteria (FLAR) among PTO cases in civilians from Syria, Iraq and Yemen admitted to the reconstructive surgical program of Médecins Sans Frontières (MSF) in Amman, Jordan, and to identify risk factors for developing PTO with FLAR bacteria.
METHODS
METHODS
We retrospectively analyzed the laboratory database of the MSF program. Inclusion criteria were: patients from Iraq, Yemen or Syria, admitted to the Amman MSF program between October 2006 and December 2016, with at least one bone biopsy sample culture result. Only bone samples taken during first orthopedic surgery were included in the analysis. To assess factors associated with FLAR infection, logistic regression was used to estimate odds ratio (ORs) and 95% confidence intervals (CI).
RESULTS
RESULTS
558 (76.7%) among 727 patients included had ≥1 positive culture results. 318 were from Iraq, 140 from Syria and 100 from Yemen. Median time since injury was 19 months [IQR 8-40]. Among the 732 different bacterial isolates, we identified 228 Enterobacteriaceae (31.5%), 193 Staphylococcus aureus (26.3%), 99 Pseudomonas aeruginosa (13.5%), and 21 Acinetobacter baumanii (2.8%). Three hundred and sixty four isolates were FLAR: 86.2% of Enterobacteriaceae, 53.4% of Pseudomonas aeruginosa, 60.5% of S. aureus and 45% of Acinetobacter baumannii. There was no difference in bacterial etiology or proportion of FLAR according to the country of origin. In multivariate analysis, a FLAR infection was associated with an infection of the lower extremity, with a time since the injury ≤12 months compared with time > 30 months and with more than 3 previous surgeries.
CONCLUSIONS
CONCLUSIONS
Enterobacteriaceae were frequently involved in PTO in war wounded civilians from Iraq, Yemen and Syria between 2006 and 2016. Proportion of FLAR was high, particularly among Enterobacteriaceae, regardless of country of origin.
Identifiants
pubmed: 30704410
doi: 10.1186/s12879-019-3741-9
pii: 10.1186/s12879-019-3741-9
pmc: PMC6357381
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103Références
Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S118-23
pubmed: 11524707
Clin Infect Dis. 2007 Aug 15;45(4):409-15
pubmed: 17638186
J Trauma. 2008 Feb;64(2 Suppl):S163-8; discussion S168
pubmed: 18376160
Pathol Biol (Paris). 2012 Jun;60(3):e15-20
pubmed: 21719212
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
J Trauma. 2011 Jul;71(1):252-4
pubmed: 21818032
J Infect. 2012 Sep;65(3):279-81
pubmed: 22490615
Clin Infect Dis. 2013 Jan;56(1):e1-e25
pubmed: 23223583
Clin Microbiol Infect. 2014 Nov;20(11):O911-9
pubmed: 24766536
Clin Infect Dis. 2014 Sep 1;59(5):753-4
pubmed: 24846634
PLoS One. 2014 Aug 11;9(8):e101017
pubmed: 25111170
J Bone Joint Surg Am. 2015 May 20;97(10):837-45
pubmed: 25995495
Medicine (Baltimore). 2015 Oct;94(42):e1874
pubmed: 26496345
Ann Clin Microbiol Antimicrob. 2016 Jan 29;15:3
pubmed: 26823288
Epidemiol Infect. 2016 Oct;144(13):2848-57
pubmed: 26931769
Jpn J Infect Dis. 2017 Jan 24;70(1):19-25
pubmed: 27000462
Clin Infect Dis. 2016 Aug 1;63(3):310-8
pubmed: 27143671
Emerg Infect Dis. 2017 Jan;23(1):166-168
pubmed: 27618479
J Infect Dev Ctries. 2016 Sep 30;10(9):947-955
pubmed: 27694727
PLoS One. 2017 Jan 13;12(1):e0170251
pubmed: 28085966
Int Orthop. 2017 Jul;41(7):1291-1294
pubmed: 28101586
J Antimicrob Chemother. 2017 Jul 1;72(7):1922-1929
pubmed: 28369408
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Emerg Infect Dis. 2017 May;23(5):885-886
pubmed: 28418320
Eur J Orthop Surg Traumatol. 2017 Oct;27(7):877-882
pubmed: 28455560
J Bone Jt Infect. 2017 May 4;2(3):149-153
pubmed: 28540152
Eur J Orthop Surg Traumatol. 2017 Oct;27(7):871-875
pubmed: 28547674
Patient Saf Surg. 2017 Jun 2;11:17
pubmed: 28588645
Trop Med Int Health. 2017 Sep;22(9):1054-1062
pubmed: 28665557
Clin Infect Dis. 2018 Feb 1;66(4):494-496
pubmed: 29020395